Literature DB >> 4521467

Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response.

J N Bickers, E A Gehan, E J Freireich, C A Coltman, H E Wilson, J S Hewlett, W J Stuckey, E J Van Slyck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4521467     DOI： 10.1001/archinte.133.2.251

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  11 in total

1.  Phase I evaluation of divided-dose vinblastine sulfate.

Authors:  P Schulman; D R Budman; V Vinciguerra; T J Degnan
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 2.  [Present state in synchronization therapy of malignant tumors and acute leukemias (author's transl)].

Authors:  H Sauer; W Wilmanns
Journal:  Klin Wochenschr       Date:  1976-03-01

Review 3.  Rate-controlled drug dosage.

Authors:  J Urquhart
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of nucleoside analogues: focus on haematological malignancies.

Authors:  S A Johnson
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

5.  Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.

Authors:  Todd L Rosenblat; Michael R McDevitt; Deborah A Mulford; Neeta Pandit-Taskar; Chaitanya R Divgi; Katherine S Panageas; Mark L Heaney; Suzanne Chanel; Alfred Morgenstern; George Sgouros; Steven M Larson; David A Scheinberg; Joseph G Jurcic
Journal:  Clin Cancer Res       Date:  2010-09-21       Impact factor: 12.531

6.  Subcutaneous infusion of cytosine arabinoside. A practical alternative to intravenous infusion.

Authors:  M L Slevin; E M Piall; G W Aherne; A Johnston; T A Lister
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  [Pharmakokinetics of hydroxy-urea. Therapy of acute myeoblastic leukemias using synchronization and recruitment effects (author' transl)].

Authors:  H Sauer; R Pelka; W Wilmanns
Journal:  Klin Wochenschr       Date:  1976-03-01

8.  The pharmacokinetics of subcutaneous bolus cytosine arabinoside in an arachis oil plus aluminium distearate suspension.

Authors:  M L Slevin; E M Piall; A Johnston; D A Levison; G W Aherne; S B Tree; T A Lister
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

9.  Remission induction and remission maintenance in adult acute nonlymphocytic leukemia employing a modified cytostatic (COAP) regimen.

Authors:  D Gerecke; W D Hirschmann; R Voigtmann; R Gross
Journal:  Blut       Date:  1979-07

10.  Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide.

Authors:  M Gore; R Powles; A Lakhani; S Milan; J Maitland; G Goss; A Nandi; T Perren; G Forgeson; J Treleaven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.